Literature DB >> 800322

Cell-mediated immunity involved in autochthonous tumor rejection in rats.

K Kikuchi, Y Ishii, H Ueno, H Koshiba.   

Abstract

Entities:  

Mesh：

Year:  1976        PMID： 800322     DOI： 10.1111/j.1749-6632.1976.tb41646.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  8 in total

1.  Immunological function of adhesive glycoprotein from rat ascites hepatoma cells: production of macrophage chemotactic lymphokine.

Authors:  M Hifumi; H Hayashi
Journal:  Immunology       Date:  1983-06       Impact factor: 7.397

2.  Immunomorphologic lymph node changes in rats bearing experimental breast tumors.

Authors:  D R Ciocca
Journal:  Am J Pathol       Date:  1980-04       Impact factor: 4.307

3.  Rat lymphocyte mitogenesis by aggregation factor from rat ascites hepatoma cell surface.

Authors:  J Kuratsu; M Yoshinaga; H Hayashi
Journal:  Br J Cancer       Date:  1978-08       Impact factor: 7.640

4.  A correlation between the expression of CD 8 antigen and specific cytotoxicity of tumor-infiltrating lymphocytes.

Authors:  Y Okada; G Yahata; S Takeuchi; T Seidoh; K Tanaka
Journal:  Jpn J Cancer Res       Date:  1989-03

5.  Two distinct mechanisms involved in the infiltration of lymphocytes into tumors.

Authors:  N Shijubo; T Uede; T Takami; Y Torimoto; D Lupin; S Min; K Kikuchi
Journal:  Jpn J Cancer Res       Date:  1988-10

6.  Immunotherapy of solid tumor by intratumoral infusion of lymphokine-activated killer cells.

Authors:  T Yamaki; Y Ibayashi; T Nakamura; N Shijubo; M Daibo; T Kawahara; K Hashi
Journal:  Jpn J Cancer Res       Date:  1988-08

7.  Functional analysis of mononuclear cells infiltrating into tumors: establishment of T cell hybridomas exhibiting distinct interacting abilities with endothelial cells and extracellular matrix components.

Authors:  E Uno; K Kikuchi; I Saiki; T Uede
Journal:  Jpn J Cancer Res       Date:  1993-12

8.  Tumor-infiltrating CD8+ T-cell density is an independent prognostic marker for oral squamous cell carcinoma.

Authors:  Shota Shimizu; Hiroyoshi Hiratsuka; Kazushige Koike; Kei Tsuchihashi; Tomoko Sonoda; Kazuhiro Ogi; Akira Miyakawa; Junichi Kobayashi; Takeshi Kaneko; Tomohiro Igarashi; Tadashi Hasegawa; Akihiro Miyazaki
Journal:  Cancer Med       Date:  2019-01-01       Impact factor: 4.452
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.